-
1
-
-
0141514427
-
Relapses of lupus nephritis: Incidence, risk factors, serology and impact on outcome
-
El Hachmi M, Jadoul M, Lefèbvre C, et al. Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome. Lupus 2003;12:692-6.
-
(2003)
Lupus
, vol.12
, pp. 692-696
-
-
El Hachmi, M.1
Jadoul, M.2
Lefèbvre, C.3
-
2
-
-
0042694721
-
Accrual of organ damage over time in patients with systemic lupus erythematosus
-
Gladman DD, Urowitz MB, Rahman P, et al. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1955-9.
-
(2003)
J Rheumatol
, vol.30
, pp. 1955-1959
-
-
Gladman, D.D.1
Urowitz, M.B.2
Rahman, P.3
-
3
-
-
65649133584
-
Prednisone, lupus activity, and permanent organ damage
-
Thamer M, Hernán MA, Zhang Y, et al. Prednisone, lupus activity, and permanent organ damage. J Rheumatol 2009;36:560-4.
-
(2009)
J Rheumatol
, vol.36
, pp. 560-564
-
-
Thamer, M.1
Hernán, M.A.2
Zhang, Y.3
-
4
-
-
81455135753
-
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
-
Dooley MA, Jayne D, Ginzler EM, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011;365:1886-95.
-
(2011)
N Engl J Med
, vol.365
, pp. 1886-1895
-
-
Dooley, M.A.1
Jayne, D.2
Ginzler, E.M.3
-
5
-
-
78649751475
-
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial
-
Houssiau FA, D'Cruz D, Sangle S, et al. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis 2010;69:2083-9.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2083-2089
-
-
Houssiau, F.A.1
D'Cruz, D.2
Sangle, S.3
-
6
-
-
0036673864
-
Immunosuppressive therapy in lupus nephritis : The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
-
Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis : the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002;46:2121-31.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2121-2131
-
-
Houssiau, F.A.1
Vasconcelos, C.2
D'Cruz, D.3
-
7
-
-
0020436689
-
The 1982 revised criteria for the classification of systemic lupus erythematosus
-
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
-
(1982)
Arthritis Rheum
, vol.25
, pp. 1271-1277
-
-
Tan, E.M.1
Cohen, A.S.2
Fries, J.F.3
-
8
-
-
84856326289
-
Therapy of lupus nephritis: Lessons learned from clinical research and daily care of patients
-
Houssiau FA. Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients. Arthritis Res Ther 2012;14:202.
-
(2012)
Arthritis Res Ther
, vol.14
, pp. 202
-
-
Houssiau, F.A.1
-
9
-
-
28144433147
-
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
-
Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219-28.
-
(2005)
N Engl J Med
, vol.353
, pp. 2219-2228
-
-
Ginzler, E.M.1
Dooley, M.A.2
Aranow, C.3
-
10
-
-
65649140169
-
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
-
Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 2009;20:1103-12.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1103-1112
-
-
Appel, G.B.1
Contreras, G.2
Dooley, M.A.3
-
11
-
-
28444437000
-
Randomized controlled trial of pulse intravenous cyclophosphamie versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis
-
Ong LM, Hooi LS, Lim TO, et al. Randomized controlled trial of pulse intravenous cyclophosphamie versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 2005;10:504-10.
-
(2005)
Nephrology (Carlton)
, vol.10
, pp. 504-510
-
-
Ong, L.M.1
Hooi, L.S.2
Lim, T.O.3
-
12
-
-
84872179222
-
Lupus nephritis: Induction therapy in severe lupus nephritis. Should MMF be considered the drug of choice?
-
Rovin BH, Parikh SV, Hebert LA, et al. Lupus nephritis : induction therapy in severe lupus nephritis. Should MMF be considered the drug of choice ? Clin J Am Soc Nephrol 2013;8:147-53.
-
(2013)
Clin J Am Soc Nephrol
, vol.8
, pp. 147-153
-
-
Rovin, B.H.1
Parikh, S.V.2
Hebert, L.A.3
-
13
-
-
84880243381
-
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
-
Condon MB, Ashby D, Pepper RJ, et al. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 2013;72:1280-6.
-
(2013)
Ann Rheum Dis
, vol.72
, pp. 1280-1286
-
-
Condon, M.B.1
Ashby, D.2
Pepper, R.J.3
-
14
-
-
84922943490
-
Biologic therapy in lupus nephritis
-
[epub ahead of print]
-
Houssiau FA. Biologic therapy in lupus nephritis. Nephron Clin Pract 2014 [epub ahead of print].
-
(2014)
Nephron Clin Pract
-
-
Houssiau, F.A.1
-
15
-
-
0022578857
-
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs
-
Austin HA III, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-19.
-
(1986)
N Engl J Med
, vol.314
, pp. 614-619
-
-
Austin, H.A.1
Klippel, J.H.2
Balow, J.E.3
-
16
-
-
1442355581
-
Sequential therapies for proliferative lupus nephritis
-
Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004;350:971-80.
-
(2004)
N Engl J Med
, vol.350
, pp. 971-980
-
-
Contreras, G.1
Pardo, V.2
Leclercq, B.3
-
17
-
-
84867424585
-
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: Data from the MAINTAIN Nephritis Trial
-
Stoenoiu MS, Aydin S, Tektonidou M, et al. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis : data from the MAINTAIN Nephritis Trial. Nephrol Dial Transplant 2012;27:1924-30.
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 1924-1930
-
-
Stoenoiu, M.S.1
Aydin, S.2
Tektonidou, M.3
-
18
-
-
84871218981
-
Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials
-
Henderson LK, Masson P, Craig JC, et al. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2013;61:74-87.
-
(2013)
Am J Kidney Dis
, vol.61
, pp. 74-87
-
-
Henderson, L.K.1
Masson, P.2
Craig, J.C.3
-
19
-
-
84898784586
-
Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: Systematic review and meta-analysis
-
Maneiro JR, Lopez-Canoa N, Salgado E, et al. Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis. Rheumatology (Oxford) 2014;53:834-8.
-
(2014)
Rheumatology (Oxford)
, vol.53
, pp. 834-838
-
-
Maneiro, J.R.1
Lopez-Canoa, N.2
Salgado, E.3
-
20
-
-
84872719028
-
Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: A meta-analysis
-
Feng L, Deng J, Huo DM, et al. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis. Nephrology (Carlton) 2013;18:104-10.
-
(2013)
Nephrology (Carlton)
, vol.18
, pp. 104-110
-
-
Feng, L.1
Deng, J.2
Huo, D.M.3
-
21
-
-
10444275010
-
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
-
Houssiau FA, Vasconcelos C, D'Cruz D, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004;50:3934-40.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3934-3940
-
-
Houssiau, F.A.1
Vasconcelos, C.2
D'Cruz, D.3
-
22
-
-
73449086703
-
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
-
Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010;69:61-4.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 61-64
-
-
Houssiau, F.A.1
Vasconcelos, C.2
D'Cruz, D.3
-
23
-
-
32444443319
-
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
-
Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006;54:421-32.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 421-432
-
-
-
24
-
-
77953956376
-
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
-
Mosca M, Tani C, Aringer M, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010;69:1269-74.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1269-1274
-
-
Mosca, M.1
Tani, C.2
Aringer, M.3
-
25
-
-
84866184129
-
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study
-
Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum 2012;64:1215-26.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 1215-1226
-
-
Rovin, B.H.1
Furie, R.2
Latinis, K.3
-
26
-
-
84896274377
-
Efficacy and safety of abatacept in lupus nephritis: A twelve-month, randomized, double-blind study
-
Furie R, Nicholls K, Cheng TT, et al. Efficacy and safety of abatacept in lupus nephritis : a twelve-month, randomized, double-blind study. Arthritis Rheumatol 2014;66:379-89.
-
(2014)
Arthritis Rheumatol
, vol.66
, pp. 379-389
-
-
Furie, R.1
Nicholls, K.2
Cheng, T.T.3
-
27
-
-
84897110519
-
Ten common mistakes in the management of lupus nephritis
-
Bose B, Silverman ED, Bargman JM. Ten common mistakes in the management of lupus nephritis. Am J Kidney Dis 2014;63:667-76.
-
(2014)
Am J Kidney Dis
, vol.63
, pp. 667-676
-
-
Bose, B.1
Silverman, E.D.2
Bargman, J.M.3
-
28
-
-
84867401561
-
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus-nephritis
-
Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus-nephritis. Ann Rheum Dis 2012;71:1771-82.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1771-1782
-
-
Bertsias, G.K.1
Tektonidou, M.2
Amoura, Z.3
-
29
-
-
84863226066
-
American College of Rheumatology guidelines for screening, treatment and management of lupus nephritis
-
Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012;64:797-808.
-
(2012)
Arthritis Care Res (Hoboken)
, vol.64
, pp. 797-808
-
-
Hahn, B.H.1
McMahon, M.A.2
Wilkinson, A.3
|